INS and metabolic dysfunction-associated steatotic liver disease: The average degree of signaling pathway was 6.25, and 7 signaling pathways were higher than this value: AMPK signaling pathway, adipocytokine signaling pathway, pathways in cancer, insulin resistance, insulin signaling pathway, non-alcoholic fatty liver disease, PI3K-Akt signaling pathway.